We serve Chemical Name:2-Chloro-4-Nitrobenzotrifluoride CAS:151504-80-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Chloro-4-Nitrobenzotrifluoride
CAS.NO:151504-80-2
Synonyms:2-chloro-4-nitro-1-(trifluoromethyl)benzene;2-Chloro-4-nitro-1-(trifluoromethyl)benzene
Molecular Formula:C7H3ClF3NO2
Molecular Weight:225.55200
HS Code:2904909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:247.4ºC at 760mmHg
Density:1.537g/cm3
Index of Refraction:1.493
PSA:45.82000
Exact Mass:224.98000
LogP:3.79020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-chloro-4-nitro-1-(trifluoromethyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-4-nitro-1-(trifluoromethyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-4-nitro-1-(trifluoromethyl)benzene Use and application,2-Chloro-4-nitro-1-(trifluoromethyl)benzene technical grade,usp/ep/jp grade.
Related News: What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. 2-Chloro-4-Nitrobenzotrifluoride manufacturer The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. 2-Chloro-4-Nitrobenzotrifluoride supplier The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 2-Chloro-4-Nitrobenzotrifluoride vendor The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 2-Chloro-4-Nitrobenzotrifluoride factory The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.
